Big Pharma Went All In to Kill Drug Pricing Negotiations Big Pharma Went All In to Kill Drug Pricing Negotiations
For more than a century, the drug industry has issued dire warnings of plunging innovation whenever regulation reared its head. In general, the threat hasn ' t materialized.Kaiser Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 12, 2022 Category: Drugs & Pharmacology Tags: Pharmacist News Source Type: news

Extreme Temperatures Can Reduce the Efficacy of Drug Therapy Extreme Temperatures Can Reduce the Efficacy of Drug Therapy
High temperatures can affect drug stability and change the way the body absorbs and excretes active ingredients.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 10, 2022 Category: Drugs & Pharmacology Tags: Pharmacist News Source Type: news

FDA Authorizes Intradermal Use of Jynneos Vaccine for Monkeypox FDA Authorizes Intradermal Use of Jynneos Vaccine for Monkeypox
The Emergency Use Authorization aims to increase vaccine supply.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 10, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news

CDC Says Recent Flu Season Mild, Maybe Owing to COVID Precautions CDC Says Recent Flu Season Mild, Maybe Owing to COVID Precautions
The mild, mainly A(H3N2)-driven 2021-2022 influenza season may have been slowed by COVID-19 precautions, CDC reports.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 8, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

1 In 8 COVID Patients Likely to Develop Long COVID: Large Study 1 In 8 COVID Patients Likely to Develop Long COVID: Large Study
Breathing difficulties, chest pain, tiredness, loss of taste and/or smell among the symptoms most likely to hang on.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - August 5, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

FDA Approves Belimumab for Children With Lupus Nephritis FDA Approves Belimumab for Children With Lupus Nephritis
Children with lupus-related kidney damage can now receive the B-cell reducing therapy that adults with lupus nephritis have been receiving for the past 2 years.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 28, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news

Guidance Abounds for Prescribing Medication Abortions Guidance Abounds for Prescribing Medication Abortions
Physicians can take advantage of simpler protocols and changes in dispensing regulations, although many barriers remain.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 27, 2022 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Half the Denosumab Dose Still Maintains Bone Density Half the Denosumab Dose Still Maintains Bone Density
Postmenopausal women with osteoporosis who reached their bone mineral density target on standard denosumab (Prolia, Xgeva) therapy maintained the benefit when they switched to a half-dose regimen.First Look (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 20, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Feds Warn Pharmacists: Don't Refuse to Provide Abortion Pills Feds Warn Pharmacists: Don't Refuse to Provide Abortion Pills
The Biden administration issued guidance to remind the nation ' s 60,000 retail pharmacies of their obligation under federal law to supply prescribed medications, including drugs that cause an abortion.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 14, 2022 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news

FDA Grants Emergency Authorization for Novavax COVID Vaccine FDA Grants Emergency Authorization for Novavax COVID Vaccine
The two-dose regimen is only for those who have not yet received any other COVID-19 vaccine.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 14, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Influenza and COVID-19 Are Colliding in Australia Influenza and COVID-19 Are Colliding in Australia
America ' s break from influenza may be at and end. What can be expected as fall approaches?Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 13, 2022 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Benzbromarone Tops Febuxostat for Gout? Benzbromarone Tops Febuxostat for Gout?
In countries where available, low-dose benzbromarone may warrant stronger consideration in gout with renal uric acid underexcretion, researchers say.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 13, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Medical Management of Miscarriage Curbs Costs and Maintains Quality of Care Medical Management of Miscarriage Curbs Costs and Maintains Quality of Care
Using mifepristone after early pregnancy or miscarriage costs less and offers similar quality of life to other treatments.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 13, 2022 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news

FDA Approves Combination Pegloticase and Methotrexate for Gout FDA Approves Combination Pegloticase and Methotrexate for Gout
Pegloticase plus methotrexate has been approved as a treatment for refractory gout.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 12, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news

California Will Make Low-Cost Insulin, Newsom Says California Will Make Low-Cost Insulin, Newsom Says
Gov. Gavin Newsom signed a state budget that includes $50 million for development of the insulin and another $50 million for a place to make it.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 8, 2022 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news